Optimal duration of dual antiplatelet therapy for coronary artery disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Optimal duration of dual antiplatelet therapy for coronary artery disease
Authors
Keywords
DAPT, Short-term, Long-term
Journal
Netherlands Heart Journal
Volume 26, Issue 6, Pages 321-333
Publisher
Springer Nature
Online
2018-04-30
DOI
10.1007/s12471-018-1113-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
- (2017) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI
- (2017) Gennaro Giustino et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Lesion Complexity and Outcomes of Extended Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
- (2017) Robert W. Yeh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials
- (2017) Francesco Costa et al. LANCET
- Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
- (2017) Dirk Sibbing et al. LANCET
- Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
- (2017) John W. Eikelboom et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT
- (2017) Paolo Zocca et al. EuroIntervention
- Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention
- (2016) Robert W. Yeh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCI
- (2016) Gennaro Giustino et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
- (2016) John A. Bittl et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
- (2016) Marc P. Bonaca et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting
- (2015) S. Schulz-Schupke et al. EUROPEAN HEART JOURNAL
- Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective
- (2015) Tomas Jernberg et al. EUROPEAN HEART JOURNAL
- Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction
- (2015) Robert W. Yeh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin
- (2015) Martine Gilard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation
- (2015) Gennaro Giustino et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials
- (2015) Tullio Palmerini et al. LANCET
- Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
- (2015) Marc P. Bonaca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
- (2015) E. P. Navarese et al. BMJ-British Medical Journal
- Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials
- (2015) E. P. Navarese et al. BMJ-British Medical Journal
- Second-Generation Drug-Eluting Stent Implantation Followed by 6- Versus 12-Month Dual Antiplatelet Therapy
- (2014) Antonio Colombo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial
- (2014) Jean-Philippe Collet et al. LANCET
- Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents
- (2014) Laura Mauri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recurrent Myocardial Infarction After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction
- (2013) Wouter J. Kikkert et al. AMERICAN JOURNAL OF CARDIOLOGY
- Meta-Analysis of Everolimus-Eluting Versus Paclitaxel-Eluting Stents in Coronary Artery Disease
- (2013) George D. Dangas et al. JACC-Cardiovascular Interventions
- Short- Versus Long-Term Duration of Dual-Antiplatelet Therapy After Coronary Stenting
- (2012) Marco Valgimigli et al. CIRCULATION
- A New Strategy for Discontinuation of Dual Antiplatelet Therapy
- (2012) Byeong-Keuk Kim et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents
- (2011) Hyeon-Cheol Gwon et al. CIRCULATION
- Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
- (2010) Seung-Jung Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
- (2009) Lars Wallentin et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started